PUBLISHER: The Business Research Company | PRODUCT CODE: 1994512
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994512
Cardiovascular repair and reconstruction devices are specialized medical tools and implantable technologies designed to restore, replace, or reconstruct damaged or diseased components of the heart and vascular system, thereby enhancing blood circulation, cardiac performance, and overall vascular health. These devices are widely used in both open surgical and minimally invasive procedures to address conditions such as coronary artery disease, congenital cardiac abnormalities, valve dysfunctions, aneurysms, and vascular injuries, supporting effective structural restoration and long-term cardiovascular function.
The primary product types of cardiovascular repair and reconstruction devices include valve repair devices, vascular grafts, occluders, annuloplasty rings, and tissue patches. Valve repair devices are used to restore impaired heart valve function and enhance blood circulation. These devices are produced from materials such as biological tissues, synthetic polymers, and metals and alloys. The applications include congenital heart defect closure, vascular reconstruction, cardiac structural repair, and other cardiovascular repair interventions, and the end users include hospitals, cardiac catheterization laboratories, ambulatory surgical centers, specialty clinics, and additional end users.
Tariffs are influencing the cardiovascular repair and reconstruction devices market by increasing costs of imported metals, biological tissues, synthetic polymers, and precision manufacturing equipment used in stents, grafts, and valve repair systems. Hospitals and cardiac centers in North America and Europe are most affected due to dependence on specialized imported components, while Asia-Pacific faces pricing pressure on export-driven device production. These tariffs are raising procurement costs and impacting device affordability. At the same time, they are encouraging domestic device manufacturing, local material sourcing, and expanded investment in regional cardiovascular implant production capabilities.
The cardiovascular repair and reconstruction devices market research report is one of a series of new reports from The Business Research Company that provides cardiovascular repair and reconstruction devices market statistics, including cardiovascular repair and reconstruction devices industry global market size, regional shares, competitors with a cardiovascular repair and reconstruction devices market share, detailed cardiovascular repair and reconstruction devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular repair and reconstruction devices industry. This cardiovascular repair and reconstruction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular repair and reconstruction devices market size has grown strongly in recent years. It will grow from $6.1 billion in 2025 to $6.65 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing incidence of congenital and structural heart diseases, expansion of cardiovascular surgical capabilities, improvements in implant material science, growing adoption of stent-based interventions, rising awareness of advanced cardiac repair options.
The cardiovascular repair and reconstruction devices market size is expected to see strong growth in the next few years. It will grow to $9.45 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac surgeries, expansion of aging population with vascular conditions, rising investments in advanced implant technologies, growth in personalized cardiovascular care, increasing adoption of hybrid surgical-interventional approaches. Major trends in the forecast period include increasing adoption of minimally invasive repair devices, rising use of bioprosthetic and hybrid implants, growing demand for customized cardiovascular implants, expansion of endovascular reconstruction techniques, enhanced focus on long-term device durability.
The growing preference for minimally invasive procedures is anticipated to drive the growth of the cardiovascular repair and reconstruction devices market in the coming years. Minimally invasive procedures refer to medical interventions performed through small incisions or natural openings that reduce tissue trauma, shorten recovery time, and lower procedural risk compared with traditional open surgery. The growing preference for minimally invasive procedures is increasing due to patient demand for faster recovery and lower procedural risks. Cardiovascular repair and reconstruction devices support this trend through widespread provision of coronary stents and delivery equipment central to percutaneous coronary interventions (PCI). For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization of board-certified plastic surgeons, minimally invasive procedures increased by 7% in 2023, exceeding the growth of traditional surgical procedures by 2%. Therefore, the growing preference for minimally invasive procedures is driving the growth of the cardiovascular repair and reconstruction devices market.
Companies operating in the cardiovascular repair and reconstruction devices market are focusing on developing advanced surgical bioprosthetic valve technologies, such as next-generation aortic tissue valves engineered for ease of implantation and future reintervention support. Next-generation aortic tissue valves are advanced bioprosthetic heart valves engineered using improved biomaterials and structural designs to replace diseased aortic valves during surgical or minimally invasive procedures, while enhancing implant ease, hemodynamic performance, durability, and compatibility with future valve-in-valve interventions. For example, in April 2024, Medtronic plc, an Ireland-based medical technology company, launched the Avalus Ultra valve, incorporating a polyetheretherketone (PEEK) base frame for consistent circularity, a low valve profile for easier implant placement, and a radiopaque coil for clear visibility during future valve-in-valve procedures, facilitating streamlined lifetime patient management. It features a polyetheretherketone (PEEK) base frame, ensuring consistent circularity during implantation. It offers an industry-leading Effective Orifice Area (EOA), potentially enabling improved blood flow as supported by clinical evidence. Additionally, the valve includes a radiopaque coil, providing clear visibility to facilitate future valve-in-valve procedures.
In February 2023, Abbott, a US-based provider of healthcare technologies including diagnostic systems, medical devices, and cardiovascular treatment solutions, acquired Cardiovascular Systems Inc. for an undisclosed amount. Through this acquisition, Abbott sought to expand and enhance its cardiovascular device portfolio by integrating CSI's innovative atherectomy technologies to better address complex peripheral and coronary artery disease treatment needs. Cardiovascular Systems Inc. is a US-based company that provides atherectomy systems, such as the Diamondback 360 Orbital Atherectomy System, used to repair and reconstruct blood vessels by removing calcified and fibrous plaque from peripheral and coronary arteries.
Major companies operating in the cardiovascular repair and reconstruction devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Stryker Corporation, Siemens Healthineers AG, Philips Healthcare, Becton Dickinson and Company, Boston Scientific Corporation, Baxter International Inc., Zimmer Biomet, Terumo Corporation, Getinge, Teleflex Incorporated, Cook Medical Inc, Merit Medical Systems, MicroPort Scientific Corporation, Shockwave, Artivion, Endologix Inc., LeMaitre Vascular Inc., W. L. Gore & Associates Inc., and Sorin Group.
North America was the largest region in the cardiovascular repair and reconstruction devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular repair and reconstruction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiovascular repair and reconstruction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cardiovascular repair and reconstruction devices market consists of sales of medical implants and instruments, vascular grafts, coronary stents, peripheral stents, heart valve prostheses, annuloplasty rings, vascular patches, and endovascular stent grafts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers of the devices, whether to other entities or directly to healthcare providers. The value of goods in this market includes related services offered by the manufacturers, such as device customization, training, and technical support.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Repair And Reconstruction Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiovascular repair and reconstruction devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular repair and reconstruction devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular repair and reconstruction devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.